Mochida Pharmaceutical Co (TSE:4534) Tariff Resilience Score: 0/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4534 Mochida Pharmaceutical Co Ltd TSE:4534
68 GF Score
Price 円3,115.00
GF Value 円3,683.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co Tariff Resilience Score?

Mochida Pharmaceutical Co has the Tariff Resilience Score of 0, which implies that the company might have .

Mochida Pharmaceutical Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Mochida Pharmaceutical Co might have .

Mochida Pharmaceutical Co  (TSE:4534) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Mochida Pharmaceutical Co Tariff Resilience Score Related Terms

TSE:4534
68GF Score
Mochida Pharmaceutical Co Ltd TSE:4534
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mochida Pharmaceutical Co (TSE:4534) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,115.00 is trading 15.4% below its estimated GF Value™ of 円3,683.67. GuruFocus considers Mochida Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4534:

  • Tariff Resilience Score: 0
  • GF Value™: 円3,683.67 vs. price of 円3,115.00 (15.4% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the TSE:4534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mochida Pharmaceutical Co Business Description

Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
68GF Score

Get the complete analysis for TSE:4534

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,115.00
Price
円3,683.67
GF Value